Michael Jahnz, PhD, MBA - Publications
Affiliations: | 2007-2015 | NOXXON Pharma | |
2008-2010 | University of Wales / Fernuni Hagen | ||
2016- | Bayer, Plano, TX, United States |
Year | Citation | Score | |||
---|---|---|---|---|---|
2015 | Achenbach J, Jahnz M, Bethge L, Paal K, Jung M, Schuster M, Albrecht R, Jarosch F, Nierhaus KH, Klussmann S. Outwitting EF-Tu and the ribosome: translation with d-amino acids. Nucleic Acids Research. PMID 26026160 DOI: 10.1093/nar/gkv566 | 0.329 | |||
2011 | Young DD, Young TS, Jahnz M, Ahmad I, Spraggon G, Schultz PG. An evolved aminoacyl-tRNA synthetase with atypical polysubstrate specificity. Biochemistry. 50: 1894-900. PMID 21280675 DOI: 10.1021/Bi101929E | 0.491 | |||
2010 | Jones DH, Cellitti SE, Hao X, Zhang Q, Jahnz M, Summerer D, Schultz PG, Uno T, Geierstanger BH. Site-specific labeling of proteins with NMR-active unnatural amino acids. Journal of Biomolecular Nmr. 46: 89-100. PMID 19669620 DOI: 10.1007/S10858-009-9365-4 | 0.513 | |||
2005 | Berezhna S, Schaefer S, Heintzmann R, Jahnz M, Boese G, Deniz A, Schwille P. New effects in polynucleotide release from cationic lipid carriers revealed by confocal imaging, fluorescence cross-correlation spectroscopy and single particle tracking. Biochimica Et Biophysica Acta. 1669: 193-207. PMID 15893522 DOI: 10.1016/J.Bbamem.2005.02.011 | 0.499 | |||
Show low-probability matches. |